Evidence map›Paper›PMID 29375382›Full record

ArticleFrontiers in pharmacology2017

Bergenin, Acting as an Agonist of PPARγ, Ameliorates Experimental Colitis in Mice through Improving Expression of SIRT1, and Therefore Inhibiting NF-κB-Mediated Macrophage Activation.

Kai Wang, Yun-Fan Li, Qi Lv, Xi-Ming Li, Yue Dai, Zhi-Feng Wei

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Integrative medicine research · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Synthetic PPAR Agonist DTMB Alleviates Alzheimer's Disease Pathology by Inhibition of Chronic Microglial Inflammation in 5xFAD Mice.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kai WangDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China.
Yun-Fan LiDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China.
Qi LvDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China.
Xi-Ming LiDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China.
Yue DaiDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China.
Zhi-Feng WeiDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China.
China Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bergenin, isolated from the herb of

Indexed as

bergeninPPARγpro-inflammatory cytokinesSIRT1ulcerative colitis

Identifiers

PMID29375382
PMCPMC5770370
OpenAlexW2784296830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.